Kevin Fischbeck
Stock Analyst at B of A Securities
(3.90)
# 464
Out of 5,182 analysts
188
Total ratings
62.88%
Success rate
5.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPCH Option Care Health | Maintains: Buy | $32 → $35 | $27.77 | +26.04% | 2 | Dec 9, 2025 | |
| ACHC Acadia Healthcare Company | Downgrades: Underperform | $22 → $13 | $27.58 | -52.86% | 9 | Dec 3, 2025 | |
| ARDT Ardent Health | Maintains: Underperform | $12 → $10 | $9.71 | +2.99% | 4 | Nov 13, 2025 | |
| HUM Humana | Maintains: Neutral | $280 → $300 | $229.72 | +30.59% | 17 | Oct 10, 2025 | |
| ELV Elevance Health | Maintains: Neutral | $330 → $370 | $362.74 | +2.00% | 4 | Oct 10, 2025 | |
| UNH UnitedHealth Group | Maintains: Neutral | $350 → $390 | $366.77 | +6.33% | 27 | Oct 8, 2025 | |
| AMN AMN Healthcare Services | Maintains: Underperform | $20 → $18 | $20.93 | -14.00% | 5 | Sep 10, 2025 | |
| DVA DaVita | Maintains: Underperform | $145 → $140 | $150.07 | -6.71% | 13 | Sep 10, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $205 → $225 | $177.50 | +26.76% | 8 | Sep 10, 2025 | |
| EHC Encompass Health | Maintains: Buy | $145 → $160 | $101.69 | +57.34% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $30 | $49.57 | -39.48% | 13 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $215 → $185 | $162.54 | +13.82% | 15 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $394 → $410 | $431.92 | -5.08% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $75 | $27.90 | +168.82% | 2 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $185.46 | +136.71% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $13.38 | -51.42% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $21.90 | -66.89% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $284.92 | +22.84% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $14.35 | +213.59% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $2.88 | +90.97% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $16.45 | +112.77% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $2.64 | +278.79% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $10.20 | -26.47% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $22.96 | - | 3 | Sep 6, 2019 |
Option Care Health
Dec 9, 2025
Maintains: Buy
Price Target: $32 → $35
Current: $27.77
Upside: +26.04%
Acadia Healthcare Company
Dec 3, 2025
Downgrades: Underperform
Price Target: $22 → $13
Current: $27.58
Upside: -52.86%
Ardent Health
Nov 13, 2025
Maintains: Underperform
Price Target: $12 → $10
Current: $9.71
Upside: +2.99%
Humana
Oct 10, 2025
Maintains: Neutral
Price Target: $280 → $300
Current: $229.72
Upside: +30.59%
Elevance Health
Oct 10, 2025
Maintains: Neutral
Price Target: $330 → $370
Current: $362.74
Upside: +2.00%
UnitedHealth Group
Oct 8, 2025
Maintains: Neutral
Price Target: $350 → $390
Current: $366.77
Upside: +6.33%
AMN Healthcare Services
Sep 10, 2025
Maintains: Underperform
Price Target: $20 → $18
Current: $20.93
Upside: -14.00%
DaVita
Sep 10, 2025
Maintains: Underperform
Price Target: $145 → $140
Current: $150.07
Upside: -6.71%
Tenet Healthcare
Sep 10, 2025
Maintains: Buy
Price Target: $205 → $225
Current: $177.50
Upside: +26.76%
Encompass Health
Sep 10, 2025
Maintains: Buy
Price Target: $145 → $160
Current: $101.69
Upside: +57.34%
Jul 16, 2025
Downgrades: Underperform
Price Target: $52 → $30
Current: $49.57
Upside: -39.48%
Jul 16, 2025
Downgrades: Underperform
Price Target: $215 → $185
Current: $162.54
Upside: +13.82%
Jul 16, 2025
Downgrades: Neutral
Price Target: $394 → $410
Current: $431.92
Upside: -5.08%
Oct 2, 2024
Downgrades: Underperform
Price Target: $75
Current: $27.90
Upside: +168.82%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $185.46
Upside: +136.71%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $13.38
Upside: -51.42%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $21.90
Upside: -66.89%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $284.92
Upside: +22.84%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $14.35
Upside: +213.59%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $2.88
Upside: +90.97%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $16.45
Upside: +112.77%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $2.64
Upside: +278.79%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $10.20
Upside: -26.47%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $22.96
Upside: -